Insights

Innovative Cancer Focus OncoSynergy is committed to developing a new class of cancer medicines aimed at maximizing patient survival and quality of life with minimal side effects, positioning it as a disruptor in oncology treatment options.

Strategic Partnerships The company's recent partnership with Infuseon Therapeutics and notable neuro-oncology experts highlights opportunities for collaborative research, joint ventures, and co-development initiatives with biotech and medical device firms.

Growing Geographical Presence Relocating headquarters to Connecticut and expanding its team provides potential for regional collaborations, local funding opportunities, and increased visibility within the U.S. biotech landscape.

Clinical Development Stage Having launched its first clinical trial for glioblastoma in 2020 indicates ongoing R&D activities, offering opportunities to supply research tools, clinical services, and biomarker solutions to support their trials.

Funding & Growth Potential With $3.3M in funding and a small team, OncoSynergy presents opportunities for early-stage investment, grant support, and strategic partnerships to accelerate clinical development and commercialization efforts.

OncoSynergy Tech Stack

OncoSynergy uses 8 technology products and services including Open Graph, MySQL, oEmbed, and more. Explore OncoSynergy's tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • GoDaddy
    Web Hosting
  • Contact Form 7
    Web Platform Extensions

OncoSynergy's Email Address Formats

OncoSynergy uses at least 1 format(s):
OncoSynergy Email FormatsExamplePercentage
First@oncosynergy.comJohn@oncosynergy.com
100%

Frequently Asked Questions

Where is OncoSynergy's headquarters located?

Minus sign iconPlus sign icon
OncoSynergy's main headquarters is located at Stamford, Connecticut 06902 United States. The company has employees across 1 continents, including North America.

What is OncoSynergy's phone number?

Minus sign iconPlus sign icon
You can contact OncoSynergy's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OncoSynergy's official website and social media links?

Minus sign iconPlus sign icon
OncoSynergy's official website is oncosynergy.com and has social profiles on LinkedInCrunchbase.

What is OncoSynergy's SIC code NAICS code?

Minus sign iconPlus sign icon
OncoSynergy's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncoSynergy have currently?

Minus sign iconPlus sign icon
As of March 2026, OncoSynergy has approximately 4 employees across 1 continents, including North America. Key team members include Vp Of Corporate & Clinical Operations | Hr Manager: A. P.Co-Founder, Chief Executive Officer, Chief Medical Officer: A. C.Co-Founder, President Chief Executive Officer: L. H.. Explore OncoSynergy's employee directory with LeadIQ.

What industry does OncoSynergy belong to?

Minus sign iconPlus sign icon
OncoSynergy operates in the Biotechnology Research industry.

What technology does OncoSynergy use?

Minus sign iconPlus sign icon
OncoSynergy's tech stack includes Open GraphMySQLoEmbedFont AwesomeGoogle Fonts APIModernizrGoDaddyContact Form 7.

What is OncoSynergy's email format?

Minus sign iconPlus sign icon
OncoSynergy's email format typically follows the pattern of First@oncosynergy.com. Find more OncoSynergy email formats with LeadIQ.

How much funding has OncoSynergy raised to date?

Minus sign iconPlus sign icon
As of March 2026, OncoSynergy has raised $3.3M in funding. The last funding round occurred on Sep 08, 2020 for $3.3M.

When was OncoSynergy founded?

Minus sign iconPlus sign icon
OncoSynergy was founded in 2011.

OncoSynergy

Biotechnology ResearchConnecticut, United States2-10 Employees

Our vision: "Cancer treatment in one dose." 

OncoSynergy is a patient-focused biotechnology startup spun out from UCSF and the JLABS South San Francisco incubator. Based in bustling Stamford, Connecticut (~40 mins from NYC), we are creating a new class of cancer medicines to maximize patient survival and quality of life with minimal side effects. We are a small, nimble startup team that launched our first clinical trial in 2020 for glioblastoma (aggressive brain cancer). 

While we are at the forefront of potential game changing research, please support our patients. They need you to spread awareness far and wide so that more research is being dedicated to devastating cancers like glioblastoma.

Section iconCompany Overview

Headquarters
Stamford, Connecticut 06902 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $3.3M

    OncoSynergy has raised a total of $3.3M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2020 in the amount of $3.3M.

  • $1M

    OncoSynergy's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $3.3M

    OncoSynergy has raised a total of $3.3M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2020 in the amount of $3.3M.

  • $1M

    OncoSynergy's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.